Table 3.
Summary of EUS-guided interventional treatment of tumors in 4 published literatures.
| Author | Year | Country | Characteristics of patients | Object of study | Treatment method | Needle type | Diameter of ablated area (cm) | Follow-up interval(months) | Complication |
|---|---|---|---|---|---|---|---|---|---|
| Carrara S et al. | 2008 | Italy | 10 liver; 9 spleen | Porcine | EUS-guided RFA | NA | Liver: <5 cm2; spleen: <6 cm2 | 1–28 days | None |
| Varadarajulu S et al. | 2009 | USA | 5 liver | Porcine | EUS-guided RFA | 19G | 2.6 (2.5–2.7) | 0–7 days | None |
| Di Matteo F et al. | 2011 | Italy | 1 HCC in the caudate lobe | Human | EUS-guided LA | 22G | 2.4*1.7 | 2 | NA |
| Park JS et al. | 2016 | Korea | 6 branch-duct intraductal papillary mucinous neoplasms | Porcine | EUS-guided RFA+EA | 18G | NA | NA | None |
HCC: Hepatocellular carcinoma;
EUS: Endoscopic ultrasonography;
RFA: Radiofrequency ablation;
LA: Laser ablation;
EA: Ethanol ablation;
NA: Not available.